OBSOLETE: Papillary fibroelastoma of the heart

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:208600
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Papillary fibroelastoma (PFE) of the heart is a rare, benign primary cardiac tumor. This Orphanet entry (208600) is classified as OBSOLETE, meaning it has been retired or reclassified within the Orphanet nomenclature, potentially merged with a broader category of cardiac tumors. Papillary fibroelastomas are the most common valvular tumors of the heart and the second most common benign cardiac tumor after myxomas. They are small, avascular, papilloma-like growths typically found on cardiac valve surfaces, most frequently the aortic valve, though they can occur on any valve or endocardial surface. Papillary fibroelastomas primarily affect the cardiovascular system. Many patients are asymptomatic, with the tumor discovered incidentally during echocardiography or cardiac surgery. However, PFEs can cause serious complications including stroke, transient ischemic attacks, peripheral embolization, and, rarely, sudden cardiac death due to coronary artery embolism. Symptoms, when present, are typically related to thromboembolic events rather than the tumor itself. The tumors are composed of avascular papillary fronds of dense connective tissue covered by endothelium, with an elastic fiber core. Treatment for symptomatic papillary fibroelastomas or those at high risk for embolization is surgical excision, which is generally curative with excellent long-term outcomes. Valve-sparing surgical techniques are preferred when possible. For asymptomatic patients with small, non-mobile tumors, conservative management with close echocardiographic surveillance may be appropriate. The etiology of PFE remains uncertain, with theories including hamartomatous origin, organized thrombus, or response to endocardial damage. These tumors are most commonly diagnosed in adults, typically in the fifth to seventh decades of life.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Papillary fibroelastoma of the heart.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Papillary fibroelastoma of the heart at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Papillary fibroelastoma of the heart community →

No specialists are currently listed for OBSOLETE: Papillary fibroelastoma of the heart.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Papillary fibroelastoma of the heart.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Papillary fibroelastoma of the heartForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Papillary fibroelastoma of the heart.

Start the conversation →

Latest news about OBSOLETE: Papillary fibroelastoma of the heart

No recent news articles for OBSOLETE: Papillary fibroelastoma of the heart.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about OBSOLETE: Papillary fibroelastoma of the heart

What is OBSOLETE: Papillary fibroelastoma of the heart?

Papillary fibroelastoma (PFE) of the heart is a rare, benign primary cardiac tumor. This Orphanet entry (208600) is classified as OBSOLETE, meaning it has been retired or reclassified within the Orphanet nomenclature, potentially merged with a broader category of cardiac tumors. Papillary fibroelastomas are the most common valvular tumors of the heart and the second most common benign cardiac tumor after myxomas. They are small, avascular, papilloma-like growths typically found on cardiac valve surfaces, most frequently the aortic valve, though they can occur on any valve or endocardial surfac

How is OBSOLETE: Papillary fibroelastoma of the heart inherited?

OBSOLETE: Papillary fibroelastoma of the heart follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does OBSOLETE: Papillary fibroelastoma of the heart typically begin?

Typical onset of OBSOLETE: Papillary fibroelastoma of the heart is adult. Age of onset can vary across affected individuals.